
Helius Medical Technologies, Inc. Class A Common Stock (DE)
HSDT
HSDT: Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, non-implantable medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.
moreShow HSDT Financials
Recent trades of HSDT by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by HSDT's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on HSDT's company Twitter account
Number of mentions of HSDT in WallStreetBets Daily Discussion
Recent insights relating to HSDT
Recent picks made for HSDT stock on CNBC
ETFs with the largest estimated holdings in HSDT
Flights by private jets registered to HSDT